India, June 4 -- Chennai-based VFL Sciences has entered a partnership with Cytosurge AG to offer the FluidFM(R) OMNIUM platform, a semi-automated single-cell manipulation system for non-destructive injection and extraction, compatible with single-cell RNA analysis and advanced gene editing techniques.

With the blend of its products and partnered products, VFL Sciences has positioned itself as a complete solution provider for several workflows in life science laboratories.

Dr Magid Haddouchi, Chief Commercial Officer at Cytosurge, stated, "India is one of the fastest-growing markets for scientific instruments, and we are excited to cooperate with VFL Sciences to grow our business further. With their experienced team, VFL Sciences will be...